Alx Oncology Holdings (ALXO) Other Working Capital Changes (2020 - 2026)
Alx Oncology Holdings (ALXO) reported Other Working Capital Changes of -$418000.0 for Q1 2026, up 17.55% on a YoY basis from -$355580.5 in Q1 2025, and down 3.47% sequentially from -$404000.0 in Q4 2025.
Alx Oncology Holdings (ALXO) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Alx Oncology Holdings (ALXO) has 7 years of Other Working Capital Changes data on file, last reported at -$418000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 17.55% year-over-year to -$418000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.8 million (up 6.52% YoY), and the FY2025 full-year result was -$1.9 million, up 7.77% from the prior year.
- Other Working Capital Changes retreated to -$418000.0 in Q1 2026, from -$404000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.3 million in Q3 2025 to a low of -$8.2 million in Q3 2024.
- A 5-year average of -$484058.8 and a median of -$12000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes surged 94.89% in 2022 and tumbled 467.8% in 2023, its largest moves.
- Tracing ALXO's Other Working Capital Changes over 5 years: stood at -$141000.0 in 2022, then sank by 159.57% to -$366000.0 in 2023, then plunged by 35.52% to -$496000.0 in 2024, then rose by 18.55% to -$404000.0 in 2025, then declined by 3.47% to -$418000.0 in 2026.
- Business Quant data shows ALXO's Other Working Capital Changes at -$418000.0 in Q1 2026, -$404000.0 in Q4 2025, and -$479000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alx Oncology Holdings | 211.24 Mn | 211.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -418,000.00 |
| Mar 31, 2026 | -418,000.00 |
| Mar 31, 2026 | -418,000.00 |
| Dec 31, 2025 | -404,000.00 |
| Dec 31, 2025 | -404,000.00 |
| Dec 31, 2025 | -404,000.00 |
| Sep 30, 2025 | -479,000.00 |
| Sep 30, 2025 | -479,000.00 |
| Sep 30, 2025 | -479,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -520,000.00 |
| Mar 31, 2025 | -507,000.00 |
| Mar 31, 2025 | -507,000.00 |
| Mar 31, 2025 | -507,000.00 |
| Dec 31, 2024 | -496,000.00 |
| Dec 31, 2024 | -496,000.00 |
| Dec 31, 2024 | -496,000.00 |
| Sep 30, 2024 | -478,000.00 |
| Sep 30, 2024 | -478,000.00 |